Advancing Vaccine Innovation: SyVento BioTech Joins World Vaccine Congress USA 2026

April 20, 2026

This week, we are heading to Warsaw. On April 22–23, the next edition of CE BioForum will bring together key leaders from the life sciences and biotechnology sectors across Central and Eastern Europe. CE BioForum is a unique platform for meaningful conversations, strategic partnerships, and insights into the latest trends shaping the biotech ecosystem. It […]

April 11, 2026

In exactly one month, SyVento BioTech will be participating in TIDES USA: Oligonucleotide & Peptide Therapeutics in Boston. This is North America’s leading conference dedicated to advancing oligonucleotide and peptide-based medicines. We will be represented on site by Sujit Jain, Commercial Advisor, who will be available to discuss collaboration opportunities and our manufacturing capabilities. Our […]

April 9, 2026

We are pleased to announce that SyVento BioTech will be exhibiting at CDMO Live 2026, one of the leading industry events dedicated to contract development and manufacturing for the pharmaceutical and biotechnology sectors. CDMO Live brings together innovators, biotech companies, and service providers to address current challenges, emerging trends, and future directions in outsourced development […]

March 30, 2026

BIO KOREA 2026 is fast approaching, taking place in Seoul next month and once again bringing together leading global stakeholders in biotechnology, pharmaceuticals, medical technology, and research. As one of the most established life‑science events in Asia, it provides a dynamic platform for partnership building, scientific exchange, and showcasing innovations that drive the future of […]

March 4, 2026

With only one month left until the 5th LNP Formulation and Process Development Summit begins in Boston, SyVento BioTech is preparing to join this leading global forum focused on advancing lipid nanoparticle science. Taking place from 6 April to 8 April 2026, the summit will bring together experts driving innovation in LNP formulation, analytical development […]

February 23, 2026

From 23–25 March 2026, industry leaders will gather in Lisbon for one of the most influential partnering events in the biotech and pharma calendar. For SyVento BioTech, this is a valuable opportunity to strengthen international collaborations, explore new strategic partnerships, and showcase how our integrated CDMO services can support next‑generation therapeutics. BIO-Europe Spring offers an […]

February 18, 2026

In just one month, we will be heading to RNA Leaders Europe 2026 taking place on 18–19 March in Vienna. We’re excited to join leading experts and innovators shaping the rapidly evolving world of RNA therapeutics. SyVento BioTech will be represented by: Eliza Milewicz, SVP, Chief Commercial Officerand Dominik Lipka, Chief Technology Officer. This event […]

December 15, 2025

  Mabion S.A. and SyVento sp. z o.o. announce the signing of a Letter of Intent to establish cooperation in the manufacturing of a medicinal product. Under the planned collaboration, SyVento will provide aseptic fill and finish services for the drug product on behalf of Mabion, in pre-filled syringe (PFS) and cartridge formats. These fill […]

November 7, 2025

We are excited to announce that SyVento BioTech will be participating in the 13th mRNA Health Conference in Berlin! This annual event will take place on 11-13 November, bringing together leading experts in hasztag#mRNA science and we are proud to be part of this important dialogue. Our representatives, Dominik Lipka PhD Eng. – CTO, and […]